AMBRISENTAN STRAGEN 5 mg, comprimé pelliculé — plaquette(s) PVC PVDC aluminium de 30 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930201367 -
CIP7
3020136 -
CIS
64414291
What the source publishes
- Holder
- STRAGEN-FRANCE
- Active ingredients
- AMBRISENTAN
- Form
- comprimé pelliculé
- Package
- plaquette(s) PVC PVDC aluminium de 30 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services CARDIOLOGIE ; prescription réservée aux spécialistes et services PNEUMOLOGIE ; prescription hospitalière ; liste I
- Marketing status
- Déclaration d'arrêt de commercialisation
- Authorised on
- 2020-03-05
- Prescription
- Prescription or restricted
Names this record is found by
- AMBRISENTAN STRAGEN 5 mg, comprimé pelliculé — plaquette(s) PVC PVDC aluminium de 30 comprimé(s)
- AMBRISENTAN STRAGEN 5 mg, comprimé pelliculé
- AMBRISENTAN
Complete source data
{
"cis": "64414291",
"cip7": "3020136",
"form": "comprimé pelliculé",
"name": "AMBRISENTAN STRAGEN 5 mg, comprimé pelliculé — plaquette(s) PVC PVDC aluminium de 30 comprimé(s)",
"cip13": "3400930201367",
"holder": "STRAGEN-FRANCE",
"routes": [
"orale"
],
"holders": [
"STRAGEN-FRANCE"
],
"currency": "EUR",
"marketed": false,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2020-03-05",
"compositions": [
{
"name": "AMBRISENTAN",
"nature": "SA",
"strength": "5 mg",
"linkageNumber": "1",
"substanceCode": "95484",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services CARDIOLOGIE ; prescription réservée aux spécialistes et services PNEUMOLOGIE ; prescription hospitalière ; liste I",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "AMBRISENTAN STRAGEN 5 mg, comprimé pelliculé",
"marketingStatus": "Déclaration d'arrêt de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "plaquette(s) PVC PVDC aluminium de 30 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2026-01-31",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"AMBRISENTAN"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services MEDECINE INTERNE",
"prescription réservée aux spécialistes et services CARDIOLOGIE",
"prescription réservée aux spécialistes et services PNEUMOLOGIE",
"prescription hospitalière",
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930201367"